Document Detail


The significance of immunoglobulins in the treatment of patients with sepsis and septic shock.
MedLine Citation:
PMID:  9623363     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Inappropriate body response is, besides the infectious agent, responsible for the genesis of sepsis and septic shock. It is non-specific and in cascade of events it can hardly be controlled. The results of immunoglobulins administration compared to the disease course and outcome have been compared and analyzed in 135 patients with sepsis and septic shock. A hundred and four patients were treated for sepsis. Immunoglobulins were administered to 18, of whom 17 patients (94.55%) were cured, while one (5.55%) developed septic shock with lethal outcome. Out of the other 86 patients who did not receive immunoglobulins, 82 (95.35%) were cured, while in 4 (4.65%) patients the outcome was lethal. No difference was observed between studied groups. Among 31 patients with septic shock, 13 received immunoglobulins. Seven (53.85%) patients were cured, and 6 (46.15%) died. In relation to the favorable disease outcome the difference was observed (statistically non-significant) in the group that received immunoglobulins, compared to the group that did not (53.85% vs. 44.45%). The importance of immunoglobulins administration, in sepsis and septic shock should be emphasized.
Authors:
I Bojić; V Begović; Z Trnjak; M Dokić
Related Documents :
17506873 - Effect of induction agent on vasopressor and steroid use, and outcome in patients with ...
16964483 - Increased colorectal permeability in patients with severe sepsis and septic shock.
10700433 - Diastolic function abnormalities in rheumatoid arthritis. evaluation by echo doppler tr...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Vojnosanitetski pregled. Military-medical and pharmaceutical review     Volume:  55     ISSN:  0042-8450     ISO Abbreviation:  Vojnosanit Pregl     Publication Date:    1998 Mar-Apr
Date Detail:
Created Date:  1998-08-24     Completed Date:  1998-08-24     Revised Date:  2008-01-09    
Medline Journal Info:
Nlm Unique ID:  21530700R     Medline TA:  Vojnosanit Pregl     Country:  YUGOSLAVIA    
Other Details:
Languages:  eng     Pagination:  75-8     Citation Subset:  IM    
Affiliation:
Military Medical Academy, Clinic for Infectious and Tropical Diseases, Belgrade.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aged
Female
Humans
Immunoglobulins, Intravenous / therapeutic use*
Male
Middle Aged
Sepsis / mortality,  therapy*
Shock, Septic / mortality,  therapy*
Survival Rate
Chemical
Reg. No./Substance:
0/Immunoglobulins, Intravenous

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  High doses of immunoglobulins decrease mortality rate of surgical patients with severe intraabdomina...
Next Document:  Treatment of IgA nephropathy with nephrotic syndrome using pulse doses of IgG.